Author:
Sazgar Mona,Young Michael G.
Publisher
Springer International Publishing
Reference129 articles.
1. Abou-Khalil BW. Antiepileptic drugs. Continuum: Lifelong Learn Neurol. 2016;22(1, Epilepsy):132–56.
2. Hauser WA, Rich SS, Annegers JF, et al. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology. 1990;40(8):1163–70.
3. Khaleghi F, Nemec EC. Brivaracetam (briviact): a novel adjunctive therapy for partial-onset seizures. Pharm Ther. 2017;42(2):92–6.
4. Zupanc ML, Roell Werner R, Schwabe MS, et al. Efficacy of felbamate in the treatment of intractable pediatric epilepsy. Pediatr Neurol. 2010;42(6):396–403.
5. Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: treatment resistant epilepsy: report of the guideline development, dissemination, and implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91(2):82–90.